ALDEYRA THERAPEUTICS INC's ticker is and the CUSIP is 01438T906. A total of 4 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $82,164 | -63.5% | 12,300 | -54.1% | 0.00% | -100.0% |
| Q2 2023 | $224,852 | +58.3% | 26,800 | +87.4% | 0.00% | 0.0% |
| Q1 2023 | $141,999 | +45.7% | 14,300 | +2.1% | 0.00% | – |
| Q4 2022 | $97,440 | -68.6% | 14,000 | -75.9% | 0.00% | -100.0% |
| Q3 2022 | $310,000 | -55.7% | 58,100 | -66.9% | 0.00% | 0.0% |
| Q2 2022 | $700,000 | +473.8% | 175,400 | +540.1% | 0.00% | – |
| Q1 2022 | $122,000 | -79.9% | 27,400 | -82.0% | 0.00% | – |
| Q4 2021 | $608,000 | -62.2% | 152,000 | -17.0% | 0.00% | -100.0% |
| Q3 2021 | $1,608,000 | +40.1% | 183,100 | +80.8% | 0.00% | +100.0% |
| Q2 2021 | $1,148,000 | +285.2% | 101,300 | +303.6% | 0.00% | – |
| Q1 2021 | $298,000 | +1195.7% | 25,100 | +638.2% | 0.00% | – |
| Q4 2020 | $23,000 | -61.7% | 3,400 | -58.0% | 0.00% | – |
| Q3 2020 | $60,000 | -64.1% | 8,100 | -79.8% | 0.00% | -100.0% |
| Q2 2020 | $167,000 | +2683.3% | 40,000 | +3536.4% | 0.00% | – |
| Q3 2019 | $6,000 | -57.1% | 1,100 | -54.2% | 0.00% | – |
| Q2 2019 | $14,000 | -91.7% | 2,400 | -87.1% | 0.00% | -100.0% |
| Q1 2019 | $168,000 | +546.2% | 18,600 | +500.0% | 0.00% | – |
| Q4 2018 | $26,000 | -85.3% | 3,100 | -75.8% | 0.00% | -100.0% |
| Q3 2018 | $177,000 | +321.4% | 12,800 | +141.5% | 0.00% | – |
| Q2 2018 | $42,000 | -27.6% | 5,300 | -31.2% | 0.00% | -100.0% |
| Q1 2018 | $58,000 | – | 7,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 58,100 | $310,000 | 0.00% |
| SIMPLEX TRADING, LLC | 10,300 | $55,000 | 0.00% |
| JANE STREET GROUP, LLC | 41,200 | $220,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |